About Pricing FAQs Providers Blog

Loading clinical trials...

Your health journey, clearly organized.

Find Clinical Trials →

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Back to clinical trial search

COMPLETEDNCT01098708

This is a Study to Get More Information About Non Ambulatory Boys & Men With Duchenne Muscular Dystrophy

Many therapeutic trials in DMD exclude non-ambulatory boys and men. Rate of progression in these non-ambulatory patients has been studied but consensus has not been reached for what measures are most ...

Lead sponsor: Washington University School of Medicine•1 U.S. locations•View source on ClinicalTrials.gov

Clareo plain-language summary

What this study is about

Generating AI summary...

Save this trial guide to your notes

Keep your clinical trial research organized — questions to ask, what to expect, and key details.

Sponsors

Lead Sponsor

Washington University School of Medicine

Collaborators

Nationwide Children's Hospital
Boston Children's Hospital
University of Minnesota
University of California, Davis

For Non-ambulatory study, boys must be unable to walk without assistive devices for greater than or equal to one year. Age at onset of study for non-ambulatory boys and men: greater than or equal to 7 years through age 22 years. Genetic or biopsy confirmation of dystrophinopathy or clinical diagnosis of DMD with biopsy/genetic confirmation in a primary relative.

Age

7 - 22 years

Sex

MALE

Healthy Volunteers

No

Inclusion Criteria

•1. For Non-ambulatory study, boys must be unable to walk without assistive devices for greater than or equal to one year.
•2. Age at onset of study for non-ambulatory boys and men: greater than or equal to 7 years through age 22 years.
•3. Genetic or biopsy confirmation of dystrophinopathy or clinical diagnosis of DMD with biopsy/genetic confirmation in a primary relative.

Exclusion Criteria

•1\. For Non-ambulatory study, the inability to understand and cooperate with the testing would exclude a subject. -

Related studies

A Remote Study Using Technology to Assess Outcomes in DMD

NCT07423026 · Duchenne Muscular Dystrophy (DMD)

RECRUITINGPhase 3

A Study of SGT-003 Gene Therapy in Ambulant Males With Duchenne Muscular Dystrophy (IMPACT DUCHENNE)

NCT07160634 · Duchenne Muscular Dystrophy

RECRUITINGPhase 1

A Study to Investigate the Safety and Biodistribution of a Single Intrathecal (IT) Injection of INS1201 in Ambulatory Males With Duchenne Muscular Dystrophy (DMD)

NCT06817382 · Duchenne Muscular Dystrophy

Establishing Walking-related Digital Biomarkers in Rare Childhood Onset Progressive Neuromuscular Disorders

NCT06839469 · Spinal Muscular Atrophy Type 3, Duchenne Muscular Dystrophy (DMD)

RECRUITINGPhase 1/2

A Study in Participants With Duchenne Muscular Dystrophy Amenable to Exon 44 Skipping to Evaluate the Safety and Efficacy of ENTR-601-44

NCT07037862 · Duchenne Muscular Dystrophy (DMD)

View all related studies →

Data from ClinicalTrials.govLast updated on ClinicalTrials.gov: January 18, 2017Terms

Trial snapshot

StatusCOMPLETED

Phase—

Enrollment50

Start dateMar 2010

Last updatedJan 18, 2017

Condition

Duchenne Muscular Dystrophy

Locations shown

Washington University

St Louis, Missouri

For caregivers

Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.

Start free trial →

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: January 18, 2017Data synced to Clareo: July 12, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions